tradingkey.logo

Avantor Inc

AVTR
11.095USD
-0.105-0.94%
Cierre 12/17, 16:00ETCotizaciones retrasadas 15 min
7.57BCap. mercado
PérdidaP/E TTM

Más Datos de Avantor Inc Compañía

Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.

Información de Avantor Inc

Símbolo de cotizaciónAVTR
Nombre de la empresaAvantor Inc
Fecha de salida a bolsaMay 17, 2019
Director ejecutivoLigner (Emmanuel)
Número de empleados13500
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 17
DirecciónRadnor Corporate Center, Building One
CiudadRADNOR
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal19087
Teléfono16103861700
Sitio Webhttps://www.avantorsciences.com/
Símbolo de cotizaciónAVTR
Fecha de salida a bolsaMay 17, 2019
Director ejecutivoLigner (Emmanuel)

Ejecutivos de Avantor Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jonathan Peacock
Mr. Jonathan Peacock
Independent Chairman of the Board
Independent Chairman of the Board
346.55K
+5.19%
Mr. Emmanuel Ligner
Mr. Emmanuel Ligner
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
283.42K
+44.66%
Mr. Christophe Couturier
Mr. Christophe Couturier
Executive Vice President, AMEA
Executive Vice President, AMEA
205.79K
+46.39%
Mr. Benoit Gourdier
Mr. Benoit Gourdier
Executive Vice President - Bioscience Production
Executive Vice President - Bioscience Production
200.69K
-0.63%
Ms. Brittany Hankamer
Ms. Brittany Hankamer
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
171.56K
-0.11%
Mr. Juan Andres
Mr. Juan Andres
Independent Director
Independent Director
57.00K
+42.85%
Dr. Michael E. Severino, M.D.
Dr. Michael E. Severino, M.D.
Independent Director
Independent Director
52.07K
+48.89%
Ms. Lan Kang
Ms. Lan Kang
Independent Director
Independent Director
43.84K
+63.95%
Ms. Kitty Sahin
Ms. Kitty Sahin
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
42.27K
-8.51%
Mr. Gregory L. (Greg) Summe
Mr. Gregory L. (Greg) Summe
Independent Chairman of the Board
Independent Chairman of the Board
39.83K
+75.24%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jonathan Peacock
Mr. Jonathan Peacock
Independent Chairman of the Board
Independent Chairman of the Board
346.55K
+5.19%
Mr. Emmanuel Ligner
Mr. Emmanuel Ligner
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
283.42K
+44.66%
Mr. Christophe Couturier
Mr. Christophe Couturier
Executive Vice President, AMEA
Executive Vice President, AMEA
205.79K
+46.39%
Mr. Benoit Gourdier
Mr. Benoit Gourdier
Executive Vice President - Bioscience Production
Executive Vice President - Bioscience Production
200.69K
-0.63%
Ms. Brittany Hankamer
Ms. Brittany Hankamer
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
171.56K
-0.11%
Mr. Juan Andres
Mr. Juan Andres
Independent Director
Independent Director
57.00K
+42.85%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Proprietary materials & consumables
893.80M
53.09%
Third party materials & consumables
789.60M
46.91%
La empresa aún no ha revelado los datos relevantes.
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Proprietary materials & consumables
893.80M
53.09%
Third party materials & consumables
789.60M
46.91%

Estadísticas de accionistas

Actualizado: lun., 17 de nov
Actualizado: lun., 17 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Dodge & Cox
17.27%
The Vanguard Group, Inc.
9.65%
BlackRock Institutional Trust Company, N.A.
7.89%
Barrow Hanley Global Investors
5.07%
T. Rowe Price Investment Management, Inc.
4.83%
Otro
55.29%
Accionistas
Accionistas
Proporción
Dodge & Cox
17.27%
The Vanguard Group, Inc.
9.65%
BlackRock Institutional Trust Company, N.A.
7.89%
Barrow Hanley Global Investors
5.07%
T. Rowe Price Investment Management, Inc.
4.83%
Otro
55.29%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
47.62%
Investment Advisor/Hedge Fund
42.40%
Hedge Fund
5.09%
Private Equity
2.13%
Research Firm
1.73%
Pension Fund
1.48%
Individual Investor
1.42%
Sovereign Wealth Fund
1.22%
Family Office
1.16%

Participación institucional

Actualizado: lun., 8 de dic
Actualizado: lun., 8 de dic
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
1132
697.26M
116.93%
+48.80K
2025Q3
1170
697.28M
119.49%
-22.58M
2025Q2
1155
719.65M
112.74%
+18.62M
2025Q1
1132
700.71M
113.08%
-69.85M
2024Q4
1131
694.99M
113.80%
-158.00
2024Q3
1115
693.95M
108.61%
+31.43M
2024Q2
1117
658.06M
105.51%
+8.42M
2024Q1
1107
649.09M
108.27%
-86.24M
2023Q4
1123
652.68M
103.73%
+15.33M
2023Q3
1111
639.87M
101.93%
+18.25M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Dodge & Cox
117.43M
17.23%
+17.17M
+17.13%
Jun 30, 2025
The Vanguard Group, Inc.
64.52M
9.46%
-112.01K
-0.17%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
55.80M
8.19%
-197.95K
-0.35%
Jun 30, 2025
Barrow Hanley Global Investors
31.19M
4.58%
+933.27K
+3.08%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
56.50M
8.29%
+14.53M
+34.62%
Jun 30, 2025
State Street Investment Management (US)
23.48M
3.44%
-113.16K
-0.48%
Jun 30, 2025
Clarkston Capital Partners, LLC
13.98M
2.05%
+4.39M
+45.77%
Jun 30, 2025
New Mountain Capital, LLC
14.00M
2.05%
--
--
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
First Trust Health Care Alphadex Fund
2.06%
John Hancock Fundamental All Cap Core ETF
1.24%
Invesco S&P MidCap Quality ETF
1.03%
First Trust Mid Cap Value AlphaDEX Fund
0.69%
Vanguard S&P Mid-Cap 400 Value Index Fund
0.55%
State Street SPDR S&P 400 Mid Cap Value ETF
0.53%
FPA Global Equity ETF
0.53%
Pacer Lunt MidCap Multi-Factor Alternator ETF
0.47%
First Trust Mid Cap Core Alphadex Fund
0.35%
NYLI Candriam US Mid Cap Equity ETF
0.35%
Ver más
First Trust Health Care Alphadex Fund
Proporción2.06%
John Hancock Fundamental All Cap Core ETF
Proporción1.24%
Invesco S&P MidCap Quality ETF
Proporción1.03%
First Trust Mid Cap Value AlphaDEX Fund
Proporción0.69%
Vanguard S&P Mid-Cap 400 Value Index Fund
Proporción0.55%
State Street SPDR S&P 400 Mid Cap Value ETF
Proporción0.53%
FPA Global Equity ETF
Proporción0.53%
Pacer Lunt MidCap Multi-Factor Alternator ETF
Proporción0.47%
First Trust Mid Cap Core Alphadex Fund
Proporción0.35%
NYLI Candriam US Mid Cap Equity ETF
Proporción0.35%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Avantor Inc?

Los cinco principales accionistas de Avantor Inc son:
Dodge & Cox posee 117.43M acciones, lo que representa el 17.23% del total de acciones.
The Vanguard Group, Inc. posee 64.52M acciones, lo que representa el 9.46% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 55.80M acciones, lo que representa el 8.19% del total de acciones.
Barrow Hanley Global Investors posee 31.19M acciones, lo que representa el 4.58% del total de acciones.
T. Rowe Price Investment Management, Inc. posee 56.50M acciones, lo que representa el 8.29% del total de acciones.

¿Cuáles son los tres principales tipos de accionista de Avantor Inc?

Los tres principales tipos de accionista de Avantor Inc son:
Dodge & Cox
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.

¿Cuántas instituciones poseen acciones de Avantor Inc (AVTR)?

A fecha de 2025Q4, 1132 instituciones poseen acciones de Avantor Inc, con un valor de mercado combinado de aproximadamente 697.26M, lo que representa el 116.93% del total de acciones. En comparación con el 2025Q3, el accionariado institucional ha aumentado en -2.55%.

¿Cuál es la mayor fuente de ganancias de Avantor Inc?

El FY2025Q2, el segmento empresarial Proprietary materials & consumables generó la ganancia más alta para Avantor Inc, ascendiendo a 893.80M y representando el 53.09% de la ganancia total.
KeyAI